phenylguanidine has been researched along with 2-aminobenzimidazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyd, S; Davidson, D; Fesik, SW; Hajduk, PJ; Nettesheim, D; Nienaber, V; Rockway, T; Severin, J; Smith, R | 1 |
| Inoue, T; Miyake, H; Morita, M; Moritomo, A; Nagashima, A; Tojo, T | 1 |
2 other study(ies) available for phenylguanidine and 2-aminobenzimidazole
| Article | Year |
|---|---|
Identification of novel inhibitors of urokinase via NMR-based screening.
Topics: Benzimidazoles; Crystallography, X-Ray; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Models, Molecular; Structure-Activity Relationship; Urokinase-Type Plasminogen Activator | 2000 |
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment.
Topics: Amine Oxidase (Copper-Containing); Amines; Animals; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Humans; Macular Edema; Male; Models, Molecular; Molecular Docking Simulation; Rats; Rats, Sprague-Dawley; Thiazoles | 2013 |